• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Vaneck Pharmaceutical ETF (NQ: PPH )

    93.51 +0.61 (+0.66%)
    Streaming Delayed Price Updated: 10:50 AM EDT, Jul 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 48,519
    Open 93.65
    Bid (Size) 93.47 (2)
    Ask (Size) 93.51 (2)
    Prev. Close 92.90
    Today's Range 92.99 - 93.65
    52wk Range 74.05 - 93.85
    Shares Outstanding N/A
    Dividend Yield 1.66%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Ozempic Maker Novo Nordisk Closes In On Lego As Denmark's Most Valuable Brand: Report
    Novo Nordisk is challenging Lego A/S for the title of Denmark's most valuable brand, with its brand value surging 59% to $5.1 billion. This growth is fueled by the global popularity of its weight-loss... 
    Via Benzinga
    Just Say No to Drugs: 3 Pharma Stocks to Avoid
    Discover which pharma stocks to avoid in 2023 as we delve into market trends, financial struggles, and the impact on investor portfolios. 
    Via InvestorPlace

    Performance

    YTD
    +13.17%
    +13.17%
    1 Month
    +1.98%
    +1.98%
    3 Month
    +6.80%
    +6.80%
    6 Month
    +9.93%
    +9.93%
    1 Year
    +16.28%
    +16.28%

    More News

    Read More
    A Look At Pharma ETFs Post Q1 Earnings
    Via Talk Markets
    Topics ETFs
    ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
    Via Talk Markets
    Topics ETFs
    3 Weight-Loss ETFs to Profit From the Obesity Drug Boom
    Via InvestorPlace
    Topics ETFs
    Novo Nordisk's Game-Changer: FDA Approves Weight Loss Sensation Wegovy For Heart Health, Potential Insurance Coverage
    Via Benzinga
    Exposures Product Safety
    The Top 3 ETFs to Buy in March 2024
    Via InvestorPlace
    Topics ETFs
    11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
    Via Benzinga
    A Look At Pharma ETFs After Q4 Earnings
    Via Talk Markets
    Topics ETFs
    5 ETF Zones Scaling New Highs At The Start Of 2024
    Via Talk Markets
    Topics ETFs
    Government-granted Patent Monopolies Are Not The Free Market
    Via Talk Markets
    Topics Intellectual Property
    Exposures Intellectual Property
    Preparing For The Next Short-Term Rally Higher
    Via Talk Markets
    Pharma ETFs in Focus Post Q2 Earnings
    Via Talk Markets
    Topics ETFs
    The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023
    Via InvestorPlace
    Pharma ETFs Gain Post Q1 Earnings
    Via Talk Markets
    A Look At Pharma ETFs Post Q4 Earnings
    Via Talk Markets
    5 Sector ETFs That Beat The Market In December
    Via Talk Markets
    Pharma ETFs In Focus Post Q3 Earnings
    Via Talk Markets
    Wave of Solid Q3 Earnings Push Pharma ETFs Higher
    Via Talk Markets
    Pharma ETFs in Focus Post Q1 Earnings
    Via Talk Markets
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.